Advertisement
Screener

PLx Pharma Winddown Corp. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

PLx Pharma Winddown Corp. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

PLx Pharma Winddown Corp. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $19.27 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-08-11

  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-12-31 was $0.00.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-09-30 was -$126.78K.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $19.74M, a 42.70% decline from fiscal 2014.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $34.46M, a 649.31% increase from fiscal 2013.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $4.60M.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 50 month
2017-06-30$19.27M
10-Q · filed 2017-08-11
2016-12-31$0.00
10-K · filed 2017-01-20
2016-06-30$1.43M
10-Q · filed 2017-08-11
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-01-20
-$126.78K
derived: sum of 2 quarters · filed 2017-01-20
$19.74M
10-K · filed 2017-01-20
2015-09-30-$126.78K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$19.74M
10-Q · filed 2016-11-09
2015-06-30$19.87M
10-Q · filed 2016-08-03
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-22
$0.00
derived: sum of 2 quarters · filed 2016-03-22
$0.00
derived: sum of 3 quarters · filed 2016-03-22
$34.46M
10-K · filed 2016-03-22
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$0.00
derived: sum of 2 quarters · filed 2015-11-13
$34.46M
10-Q · filed 2015-11-13
$35.39M
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$34.46M
10-Q · filed 2015-08-12
$35.39M
derived: sum of 3 quarters · filed 2015-08-12
$36.81M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$34.46M
10-Q · filed 2015-05-13
$35.39M
derived: sum of 2 quarters · filed 2015-05-13
$36.81M
derived: sum of 3 quarters · filed 2015-05-13
$38.16M
derived: sum of 4 quarters · filed 2015-05-13
$44.13M
10-Q · filed 2014-05-12
2013-12-31$937.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$2.36M
derived: sum of 2 quarters · filed 2015-03-23
$3.71M
derived: sum of 3 quarters · filed 2015-03-23
$4.60M
10-K · filed 2015-03-23
2013-09-30$1.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$2.77M
derived: sum of 2 quarters · filed 2014-11-12
$3.66M
10-Q · filed 2014-11-12
2013-06-30$1.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$2.24M
10-Q · filed 2014-08-12
2013-03-31$892.50K
10-Q · filed 2014-05-12